drugset / Trial / NCT01332201

Study to Compare the Pharmacokinetics of Tacrolimus in Adult Transplant Recipients Treated With Advagraf® or Prograf®

NCT01332201 ↗

Phase 2 Completed 17 enrolled Astellas Pharma Inc
RandomizedParallel-groupOpen-labelPrevention

Summary

Comparison of tacrolimus blood levels in adults who have received a transplant and are taking either Prograf or Advagraf anti-rejection therapy immediately following surgery. This is followed by checking of safety and effectiveness for one year.

Timeline

Start
2011-07
Primary completion
2013-11
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tacrolimus Small molecule — Oral

Indications

No indication recorded.